Bzam Stock Price, News & Analysis
Company Description
Bzam (OTC Link: BZAMF) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $2.7K.
BZAMF stock has gained 0.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of BZAMF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Bzam (BZAMF) stock last traded at $0.0000. At a market capitalization of $2.7K, BZAMF is classified as a micro-cap stock with approximately 180.8M shares outstanding.
Latest News
Bzam has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include acquisition, earnings, private placement. View all BZAMF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Bzam (BZAMF) currently stands at 22.8 thousand shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Bzam (BZAMF) currently stands at 4.7 days, down 89.9% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has decreased 90.5% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 3.4 to 232.8 days.
BZAMF Company Profile & Sector Positioning
Bzam (BZAMF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing BZAMF often look at related companies in the same sector, including Juva Life (JUVAF), Bloomios Inc (BLMS), Item 9 Labs (INLB), 1CM (MILFF), and Halo Collective Inc (HCANF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BZAMF's relative position within its industry.